Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects

Jing Ma, Max Bellon, Judith M Wishart, Richard Young, L Ashley Blackshaw, Karen L Jones, Michael Horowitz, Christopher K Rayner, Jing Ma, Max Bellon, Judith M Wishart, Richard Young, L Ashley Blackshaw, Karen L Jones, Michael Horowitz, Christopher K Rayner

Abstract

The incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), play an important role in glucose homeostasis in both health and diabetes. In mice, sucralose, an artificial sweetener, stimulates GLP-1 release via sweet taste receptors on enteroendocrine cells. We studied blood glucose, plasma levels of insulin, GLP-1, and GIP, and gastric emptying (by a breath test) in 7 healthy humans after intragastric infusions of 1) 50 g sucrose in water to a total volume of 500 ml (approximately 290 mosmol/l), 2) 80 mg sucralose in 500 ml normal saline (approximately 300 mosmol/l, 0.4 mM sucralose), 3) 800 mg sucralose in 500 ml normal saline (approximately 300 mosmol/l, 4 mM sucralose), and 4) 500 ml normal saline (approximately 300 mosmol/l), all labeled with 150 mg 13C-acetate. Blood glucose increased only in response to sucrose (P<0.05). GLP-1, GIP, and insulin also increased after sucrose (P=0.0001) but not after either load of sucralose or saline. Gastric emptying of sucrose was slower than that of saline (t50: 87.4+/-4.1 min vs. 74.7+/-3.2 min, P<0.005), whereas there were no differences in t50 between sucralose 0.4 mM (73.7+/-3.1 min) or 4 mM (76.7+/-3.1 min) and saline. We conclude that sucralose, delivered by intragastric infusion, does not stimulate insulin, GLP-1, or GIP release or slow gastric emptying in healthy humans.

Figures

Fig. 1.
Fig. 1.
Concentrations of blood glucose (A), plasma insulin (B), plasma glucagon-like peptide-1 (GLP-1) (C), and plasma glucose-dependent insulinotropic polypeptide (GIP) (D) in response to intragastric infusion of 500 ml solutions containing either 1) 50 g sucrose, 2) normal saline, 3) 80 mg sucralose (0.4 mM), or 4) 800 mg sucralose (4 mM) in 7 healthy subjects. *Sucrose vs. saline, P < 0.05. Data are means ± SE. There were no significant differences in blood glucose, plasma insulin, plasma GLP-1, and plasma GIP between either load of sucralose and saline.

Source: PubMed

Подписаться